Company / Working Capital per Share
Oruka Therapeutics, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.78
FY2024
5-year range
-$0.78 / $29.15
FY2020-FY2024
Trend
-130.3%
vs FY2023
Sector context
#208 of 210
Health Care
What the data says
Among 210 Health Care companies, Oruka Therapeutics, Inc. is in the bottom 1% for working capital per share. Working Capital per Share has declined for 4 consecutive years, from $29.15 in FY2020 to $-0.78 in FY2024.
Based on SEC 10-K filings.
-0.78 in FY2024.
Declined from $2.88 to $-0.78 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company -$0.78 Sector average $118.60
▼
-100.7% below sector average
Key checks
Key Insights
- Oruka Therapeutics, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2024, working capital per share decreased 130.3% year-over-year.
- Ranks #208 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.78 | -130.3% |
| FY2023 | $2.56 | -11.1% |
| FY2022 | $2.88 | -45.9% |
| FY2021 | $5.33 | -81.7% |
| FY2020 | $29.15 | +198.5% |
| FY2019 | $9.77 | +1821.6% |
| FY2018 | $0.51 | -54.9% |
| FY2017 | $1.13 | -46.5% |
| FY2016 | $2.10 | -83.0% |
| FY2015 | $12.38 | +1277.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026